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Abstract 
Non‑O1, non‑O139 Vibrio cholerae (NOVC) are increasingly frequently observed ubiquitous microorganisms occa‑
sionally responsible for intestinal and extra‑intestinal infections. Most cases involve self‑limiting gastroenteritis or 
ear and wound infections in immunocompetent patients. Bacteraemia, which have been described in patients with 
predisposing factors, are rare and poorly known, both on the clinical and therapeutic aspects. We describe a case of 
NOVC bacteraemia and a systematic literature review in PubMed conducted up to November 2014 using a combina‑
tion of the following search terms: “Vibrio cholerae non‑O1” and “bacter(a)emia”. The case was a 70 year‑old healthy 
male subject returning from Senegal and suffering from NOVC bacteraemia associated with liver abscesses. Disease 
evolution was favourable after 2 months’ therapy (ceftriaxone then ciprofloxacin). Three hundred and fifty cases of 
NOVC bacteraemia have been identified in the literature. The majority of patients were male (77 %), with a median 
age of 56 years and presenting with predisposing conditions (96 %), such as cirrhosis (55 %) or malignant disease 
(20 %). Diarrhoea was inconstant (42 %). Mortality was 33 %. The source of infection, identified in only 25 % of cases, 
was seafood consumption (54 %) or contaminated water (30 %). Practitioners should be aware of these infections, in 
order to warn patients with predisposing conditions, on the risk of ingesting raw or undercooked seafood or bathing 
in potentially infected waters.
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Background
The genus Vibrio belongs to the Vibrionaceae family. 
Vibrio species are halophilic facultative anaerobic Gram-
negative bacilli, which are ubiquitously distributed in 
marine and estuarine environments. Their presence is 
particularly well documented in Asia and Latin America 
and in the coastal waters of the Gulf of Mexico. Their 
density is increasing, particularly in filter-feeding shell-
fish, associated with high surface water temperature, 
especially during warmer months (13–25 °C), secondary 
to the proliferation of phytoplankton and zooplankton 
(Crim et al. 2014; Harris et al. 2012; Huehn et al. 2014). 
There is an increasing trend towards infection due to 
Vibrio. Despite under-diagnosis and under-reporting, 
especially for milder cases, they are the 6th pathogen 
transmitted through food in the USA, after Salmonella, 
Campylobacter, Shigella, Cryptosporidium and Shiga 
toxin-producing Escherichia coli (Crim et  al. 2014; 
Huehn et al. 2014).
Over 200 serogroups compose the V. cholerae species, 
based on the surface O antigen of the lipopolysaccharide 
(Harris et  al. 2012). The two major serogroups, O1 and 
O139, are responsible for epidemic cholera, an acute diar-
rheal disease leading to 28,000–142,000 deaths every year, 
according to the WHO. Bacteraemia associated with chol-
eragenic vibrios is rare, possibly thanks to the ability of the 
cholera toxin, a non-invasive enterotoxin, to suppress induc-
tion of inflammation during infection (Fullner et al. 2002).
Non-choleragenic vibrios, including the other sero-
groups of the V. cholerae species, and other species of 
Vibrio, mainly V. alginolyticus, V parahaemolyticus and 
V. vulnificus, can lead to intestinal infections (gastroen-
teritis) as well as extra-intestinal manifestations (wound 
infections, external otitis and bacteraemia) through inva-
sive mechanisms, with significant mortality.
Open Access
*Correspondence:  delablanchardiere‑a@chu‑caen.fr 
1 Service des Maladies Infectieuses et Tropicales, CHU Côte de Nacre, 
avenue Côte de Nacre, 14033 Caen Cedex 9, France
Full list of author information is available at the end of the article
Page 2 of 9Deshayes et al. SpringerPlus  (2015) 4:575 
In recent years, there has been an increase in the num-
ber of reports of infections involving non-O1, non-O139 
V. cholerae (NOVC). The majority were case reports of 
self-limiting gastroenteritis, ear and wound infections 
in immunocompetent patients or bacteraemia in immu-
nocompromised hosts with predisposing medical condi-
tions (Petsaris et al. 2010).
However, NOVC infection may rarely lead to invasive 
extraintestinal infection and potentially fatal bacterae-
mia in healthy patients (Mannion and Mellor 1986). We 
report a case of NOVC bacteraemia with liver abscesses 
in a French immunocompetent male subject returning 
from Senegal, and discuss the epidemiology, the clinical 
manifestations, the predisposing factors and the antimi-
crobial therapy of NOVC bacteraemia through a review 
of 350 identified cases.
Methods
A review of the literature in English, French and Span-
ish was conducted via an electronic search on MEDLINE 
by crossing the key words “Vibrio cholerae non-O1” and 
“bacter(a)emia”. We also retrieved the articles in the ref-
erence lists of papers found in our searches. The litera-
ture search period ranged from the first described case in 
1974 to November 2014.
Statistical analysis was performed using R 3.0.3 statisti-
cal software. Categorical variables were reported as per-
centages and compared using Chi square or Fisher’s exact 
tests according to expected frequencies. Continuous 
variables were expressed as means and analysed using 
Student’s t-test. A p-value <0.05 was considered to be sta-
tistically significant.
Case report
A 70 year-old man was referred to the Infectious Diseases 
Unit in our institution in April 2010 for fever and watery 
diarrhoea, after spending 3 weeks in Senegal.
The patient presented with a previous history of myo-
cardial infarction, hypertension, hepatitis A in 1954 and 
cholecystectomy. No alcohol abuse, malignant or immu-
nocompromising disease was reported.
The patient presented with a single episode of watery 
diarrhoea, vomiting and dizziness associated with a short 
loss of consciousness on the day of his return to France 
and a 3-kg weight loss. Over the following days, he com-
plained of high fever with chills and abdominal pain. The 
patient stated no history of bathing in the sea or in fresh 
water; however, he reported important consumption of 
fish and shellfish, sometimes undercooked, whereas no 
other case was reported among his fellow travellers.
On arrival, his body temperature was 38.1  °C and his 
vital signs were stable. The results of physical examina-
tion were normal with the exception of abdominal ten-
derness, mainly on the upper right quadrant. No jaundice 
was reported.
Laboratory tests revealed an increased white blood 
cell count (13  ×  109/L) and elevated C-reactive pro-
tein (397 mg/L). Serum creatinine was within the refer-
ence range. Liver function test results were elevated, 
including aspartate aminotransferase, 119  IU/L; alanine 
aminotransferase, 216  IU/L; and alkaline phosphatase, 
163  IU/L, without hepatocellular insufficiency. Abdomi-
nal ultrasonography revealed two heterogenous collec-
tions from 3 to 5  cm in the right liver compatible with 
abscesses, confirmed by CT scan (Fig. 1). Neither of the 
two imaging techniques showed any signs of underlying 
chronic hepatopathy, nor damage on biliary ducts or por-
tal vessel. One of the two sets of blood cultures collected 
upon admission yielded a Gram-negative rod, compatible 
with V. cholerae (Fig. 2). Stool cultures were negative. The 
strain was sent to the French National Reference Center 
for Vibrios and Cholera (CNRVC, Institut Pasteur, Paris, 
France) for confirmation of the identification by bio-
chemical, molecular and cultural methods, agglutination 
Fig. 1 Abdominal CT showing two low density lesions in the right liver (arrows), compatible with the diagnosis of liver abscesses
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with O1 and O139 antisera and search for virulence fac-
tors. The strain did not agglutinate when tested against 
O1 or O139 antisera. PCR techniques demonstrated the 
absence of the major virulence-encoding genes of toxi-
genic V. cholerae, the cholera-toxin (ctxA and ctxB) and 
the toxin-coregulated pilus (tcpA) virulence genes, and of 
the stn gene, encoding a heat-stable enterotoxin reported 
to contribute to the pathogenicity of NOVC. PCR was 
positive for the El-Tor hlyA gene. The bacteria was sen-
sitive to amoxicillin, cefotaxime, ofloxacin, gentamicin, 
cotrimoxazole. 
Empirical parenteral treatment with intravenous ceftri-
axone (1 g every 24 h) was initiated then shifted to oral 
ciprofloxacin (500 mg every 12 h) after 15 days. Clinical 
evolution was favourable, with a rapid decrease in fever 
and resolution of abdominal pain. After 2 months’ treat-
ment, abdominal ultrasound did not reveal any residual 
collection and antibiotic therapy was stopped.
Results of the literature review
One hundred and twenty-eight articles described 350 
cases of NOVC bacteraemia involving 347 patients, 3 
of whom presented with a second episode (Additional 
file 1: Table S1) (Petsaris et al. 2010; Mannion and Mel-
lor 1986; Lai et  al. 2012; Morris et  al. 1981; Anderson 
et  al. 2004; Pierce et  al. 2000; Hlady and Klontz 1996; 
Magnusson and Pegg 1996; Robins-Browne et  al. 1977; 
Eltahawy et al. 2004; Marcenac et al. 1991; Ferreira et al. 
2012; Zarate et al. 2011; Goei and Karthigasu 1978; Tru-
biano et  al. 2014; Heath et  al. 2001; Guard et  al. 1980; 
Hsu et al. 2013; Huhulescu et al. 2007; Halabi et al. 1997; 
Berghmans et al. 2002; Kadkhoda et al. 2012; Burns et al. 
1989; Ramsingh 1998; Briceno et  al. 2009; Young et  al. 
1991; Lu et al. 2014; Farmachidi et al. 2003; Chong et al. 
1985; Choi et al. 2003; Dalsgaard et al. 2000; Marek et al. 
2013; Aguinaga et al. 2009; Forné et al. 1987; Prats et al. 
1975; Lopez-Brea et  al. 1985; Mirelis et  al. 1987; Royo 
et al. 1993; Mauri et al. 1987; Esparcia et al. 2000; Fernán-
dez et al. 2000; Lantero et al. 1984; Folgueira et al. 1991; 
Fernández-Monrás et al. 1990; Catalá Barceló MT 1998; 
Fernández-Natal and Alcoba-Leza 1996; Calduch Bro-
seta JV 2003; Rabadan and Vilalta 1989; Rubin et al. 1981; 
Nedunchezian et al. 1994; Pitrak and Gindorf 1989; Bon-
ner et al. 1983; Newman et al. 1993; Namdari et al. 2000; 
Patel et  al. 2009; Wagner et  al. 1995; Siegel and Rogers 
1982; McCleskey et  al. 1986; Florman et  al. 1990; West 
et  al. 1998; Klontz 1990; Hughes et  al. 1978; Restrepo 
et  al. 2006; Safrin et  al. 1988; Fearrington et  al. 1974; 
Shannon and Kimbrough 2006; Platia and Vosti 1980; 
Kontoyiannis et al. 1995; Shelton et al. 1993; Crump et al. 
2003; Naidu et  al. 1993; Morgan et  al. 1985; Lukinmaa 
et al. 2006; Blanche and Sicard 1994; Moinard et al. 1989; 
Laudat et  al. 1997; Raultin and de La Roy, 1981; Couz-
igou et  al. 2007; Issack et  al. 2008; Kerketta et  al. 2002; 
Thomas et al. 1996; Lalitha et al. 1986; George et al. 2013; 
Raju et al. 1990; Khan et al. 2013; Toeg et al. 1990; Ruden-
sky et al. 1993; Farina et al. 1999; Piersimoni et al. 1991; 
Ismail et  al. 2001; Dhar et  al. 1989, 2004; Phetsouvanh 
et al. 2008; Feghali and Adib 2011; Tan et al. 1994; Deris 
and Leow 2009; Whittaker 2013; Stypulkowska-Misi-
urewicz et  al. 2006; Albuquerque et  al. 2013; El-Hiday 
and Khan 2006; Khan et  al. 2007; Strumbelj et  al. 2005; 
Wiström 1989; Lin et al. 1996; Ko et al. 1998; Lee et al. 
1993; Chang-Chien 2006; Tsai and Huang 2009; Chan 
et al. 1994; Yang et al. 2008; Cheng et al. 2004; Tsai et al. 
2004; Wang et al. 1991; Laosombat et al. 1996; Punpanich 
Fig. 2 a Gram stain (magnificence ×1000) and b colonial morphology of non‑O1, non‑O139 V. cholerae grown on Trypticase‑Soy agar after 18 h of 
aerobic incubation at 35 °C (Photos M. Auzou)
Page 4 of 9Deshayes et al. SpringerPlus  (2015) 4:575 
et  al. 2011; Thisyakorn and Reinprayoon 1990; Luxsa-
meesathaporn et al. 2012; Suankratay et al. 2001; Wiwat-
worapan and Insiripong 2008; Boukadida et al. 1993; Lan 
et al. 2014; Geneste et al. 1995; Yang et al. 2011; Thomas 
et al. 2007; Ou et al. 2003; Lee et al. 2007; Thamlikitkul 
1990; Jesudason et al. 1991). The majority of articles were 
case reports, the largest series including 69 cases of bac-
teraemia (Ou et al. 2003). The first case was described in 
the USA in 1974 (Fearrington et al. 1974). One hundred 
and fifty-six cases (45 %) originated from Taiwan, 60/350 
(20  %) from the USA and 21/350 (6  %) from Spain. 
Although NOVC strains are frequently found in coastal 
waters, only two cases have been reported in Africa. Two 
possible explanations are under-diagnosis due to lack of 
resources, and the non reporting of clinical cases. Includ-
ing our own case report, 12 cases of NOVC bacteraemia 
have been published in France, in summer or autumn, 
including four imported cases from Tunisia (2), Morocco 
(1) and Senegal (1) (Farmachidi et al. 2003; Blanche and 
Sicard 1994; Moinard et al. 1989; Laudat et al. 1997; Raul-
tin and de La Roy, 1981; Couzigou et al. 2007).
NOVC infection predominantly affected middle-aged 
male subjects (median age 56  years, sex-ratio 3.3) and 
rarely children <18 years (4.6 %). The main risk factor for 
NOVC bacteraemia was cirrhosis (54 %). Other risk fac-
tors were cancer or malignant blood diseases, alcoholism, 
other liver diseases, diabetes, and iatrogenesis (Addi-
tional file 1: Table S1).
When specified, the source of NOVC bacteraemia was 
most often seafood consumption (53.9 %) including oys-
ters (9/22, 41 %), fish (5/22, 23 %), shrimps (4/22, 18 %), 
clams (2/22, 9  %), mussels (1/22, 4  %) and apple snail 
(1/22, 4 %) (Additional file 1: Table S1) (Crim et al. 2014; 
Morris et  al. 1981; Anderson et  al. 2004; Pierce et  al. 
2000; Trubiano et al. 2014; Halabi et al. 1997; Dalsgaard 
et al. 2000; Marek et al. 2013).
The clinical presentation of bacteraemia was most 
often hypo or hyperthermia, diarrhoea and abdomi-
nal pain. Jaundice and ascites were probably linked to 
cirrhosis (Additional file  1: Table  S1). When specified, 
diarrhoea was most often watery (20/25, 80  %), rarely 
bloody (12  %) or with mucous (8  %). Including our 
patient, five hepatic abscesses were described, one of 
which yielded sterile blood cultures (Guard et al. 1980; 
Farmachidi et  al. 2003; Strumbelj et  al. 2005; Lai et  al. 
2011). Two cases of pyomyositis were also reported 
(Nedunchezian et al. 1994; Couzigou et al. 2007), as well 
as one prostatic abscess (Safrin et al. 1988), one cerebral 
abscess (Morgan et al. 1985) and one peritoneal abscess 
(Stypulkowska-Misiurewicz et al. 2006). This significant 
frequency of abscess, almost 5 %, had not been reported 
to date.
One-third of patients with NOVC bacteraemia died.
Prognostic factors were studied based on articles for 
which clinical outcomes were known. Hypotension and 
confusion or coma were statistically associated with a 
higher mortality, whereas digestive surgery was associ-
ated with better outcome (Additional file 1: Table S2).
Discussion
This work represents the largest literature review on epi-
demiology, risk factors and prognosis of an unusual and 
potentially emerging pathogen, namely, non-O1, non-
O139 V. cholerae.
The three main clinical presentations of NOVC infec-
tion are gastroenteritis, wound and ear infections and 
bacteraemia, the latter being the least frequent (Petsaris 
et  al. 2010). However, strains have been isolated from 
various other sites, such as respiratory tract, bile, uterus, 
urine and cerebrospinal fluid (Lai et  al. 2012). Gastro-
enteritis can be mild to severe, with watery more often 
than bloody stools, but, in all cases, prognosis is favour-
able (Morris et al. 1981; Anderson et al. 2004). They are 
however under-diagnosed, partly due to the failure of 
both clinicians and microbiologist to suspect vibrios 
as etiological agents of diarrhoea, and to the fact that 
many laboratories do not use the appropriate enrichment 
and culture media, such as thiosulfate-citrate-bile salt-
sucrose (TCBS) agar, to isolate these organisms (Pierce 
et al. 2000). Between 1 and 3.4 % of cases of acute diar-
rhoea are believed to be due to NOVC, in developing 
and developed countries alike (Luo et  al. 2013). NOVC 
grows in routine blood culture media. However, due to 
its rarity, NOVC bacteraemia is relatively unknown [17 % 
of NOVC infections in Florida were bacteraemia (Hlady 
and Klontz 1996)].
Most bacteraemia cases are associated with expo-
sure to aquatic environments or seafood consumption, 
with 5.6 % of seafood samples tested in Italy positive for 
NOVC (Ottaviani et al. 2009), and more than one-third 
of seafood samples tested in Germany (Huehn et al. 2014; 
Cheasty et al. 1999). Bacteria may shift from the intestine 
to the blood through the portal vein or intestinal lym-
phatic system (Bonner et  al. 1983). However, in almost 
75  % of cases, no exposure to aquatic environments or 
seafood consumption was reported, suggesting other 
infection routes (Additional file  1: Table  S1). Indeed, 
NOVC strains have been isolated from wild and domestic 
animals (Cheasty et al. 1999), while asymptomatic human 
carriage has also been described and two outbreaks of 
NOVC gastroenteritis have been linked to the consump-
tion of grated eggs and potatoes (Morris et al. 1981; Dhar 
et al. 2004). NOVC can grow in water with low salinity, 
such as alkaline lakes, artificial waterways and sewers. It 
has been documented in French coastal waters (Hervio-
Heath et al. 2002).
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Subtyping methods, such as Pulsed Field Gel electro-
phoresis analysis, indicated that NOVC strains showed 
considerable diversity. The mechanisms underlying their 
virulence and in particular their capacity to invade the 
bloodstream are still not fully understood. These strains 
normally lack most of the major virulence-encoding 
regions of toxigenic V. cholerae (such as cholera toxin 
or toxin-coregulated pilus), but their pathogenicity has 
been associated with other virulence factors. Among 
them, a type III secretion system has been demonstrated 
to be involved in colonization (Chaand et  al. 2015), a 
heat-stable enterotoxin (ST), encoded by the stn gene, 
was reported to contribute to the pathogenicity of these 
strains in case of gastroenteritis (Morris et  al. 1990), a 
haemagglutinin protease (HA/P), and a haemolysin, pre-
sent in V. cholerae O1, was suggested to be involved in 
the enteroinvasiveness of some NOVC isolates (Namdari 
et al. 2000; Luo et al. 2013; Ottaviani et al. 2009; Awasthi 
et  al. 2013; Schirmeister et  al. 2014). However, the lack 
of detection of stn gene in most of the strains associated 
with gastroenteritis (data from the CNRVC), the pres-
ence and expression of hlyA genes in strains isolated 
from patients without extraintestinal infection (Ottavi-
ani et al. 2009, and data from the CNRVC) and its wide-
spread occurrence among environmental strains, suggest 
that there are additional virulence factors.
Occurrence of NOVC bacteraemia is dependent on the 
infecting strain, but also on the health and immune status 
of the host. The main risk factor of NOVC bacteraemia is 
cirrhosis (54 %). Cirrhotic patient susceptibility to NOVC 
bacteraemia is thought to be linked to inflammation and 
oedema of intestinal mucosa with increased intestinal 
permeability, by-pass of the hepatic reticuloendothelial 
system by portal hypertension, weak opsonic activity of 
ascetic fluid, impairment of phagocytosis, complement 
deficiencies, alteration of iron metabolism and/or inhi-
bition of chemotaxis, the precise role of each defence 
mechanism defect requiring further study (Anderson 
et al. 2004; Bonner et al. 1983; Couzigou et al. 2007; Ko 
et al. 1998).
In published cases of NOVC bacteraemia, there is 
extreme heterogeneity in antimicrobial therapy (in terms 
of the nature of antimicrobial agent(s), their dosage and 
treatment duration). In cholera, antimicrobial therapy, 
although adjunctive, is relatively well codified, reduc-
ing total stool volume by 50  %, the duration of shed-
ding of viable organisms in stools from several days to 
1–2 days and the quantity of rehydration fluids by 40 %. 
Tetracycline and azithromycin appear to be first-choice 
antibiotics (Leibovici-Weissman et  al. 2014). Because 
NOVC bacteraemia is rare, no large-scale trials have 
been conducted. While spontaneous recovery is the 
rule in NOVC gastroenteritis, antimicrobial therapy is 
recommended in complicated forms and/or in immu-
nocompromised patients, with a dual-agent therapy 
in NOVC bacteraemia according to certain authors 
(Couzigou et  al. 2007). Tetracyclines are widely used, 
by analogy with cholera and because they inhibit pro-
tein synthesis, which may decrease the production of 
toxins (Leibovici-Weissman et al. 2014). Ko et al. (1998) 
reported the synergistic effect, both in vitro and in mice, 
of cefotaxime plus minocycline in V. vulnificus infec-
tions. Thus, the association of third-generation cephalo-
sporins with a tetracycline or fluoroquinolones may offer 
an interesting alternative in the treatment of NOVC 
bacteraemia, depending on local antibiotic susceptibility 
testing, although recommendations regarding the choice 
of therapy are not conclusive. Furthermore, several 
cases of antimicrobial resistance have been described 
in environmental as well as in clinical strains, involving 
cefotaxime, nalidixic acid, tetracyclines, cotrimoxazole, 
ciprofloxacin and depending on location, certain mul-
tidrug resistant strains having been reported, particu-
larly in India (Lu et al. 2014; Luo et al. 2013; Jagadeeshan 
et  al. 2009). The duration of treatment is also a mat-
ter of debate, ranging from 3 to 75 days with a median 
of 14  days (Additional file  1: Table  S1). This duration 
should probably be adapted according to the patient’s 
background, clinical presentation and severity (such as 
meningitis and abscess).
In our review, we didn’t observe a higher risk of mortal-
ity in patients with cirrhosis, neoplasia and iatrogenesis, 
unlike Ou et al. (2003). Unsurprisingly, the onset of circu-
latory or neurological failure was statistically associated 
with higher mortality. Digestive surgery seems paradoxi-
cally protective, because it does not impair the immune 
system, as do cirrhosis or cancer. The high mortality of 
bacteremia NOVC is probably due to delayed diagnosis, 
inadequate antimicrobial therapy and/or too short ther-
apy duration.
Conclusions
Ongoing global warming, anthropisation of coastal envi-
ronments, international seafood trade, consumption of 
undercooked seafood and increase in individuals at risk 
will undoubtedly increase NOVC infections, especially 
in summer, as already demonstrated in the Baltic Sea 
(Huehn et  al. 2014; Schirmeister et  al. 2014), and will 
render NOVC infection an under-diagnosed, life-threat-
ening, emerging infectious disease, involving economic 
issues (seafood importation) (Robert-Pillot et  al. 2014). 
NOVC strains have been confirmed as potential contam-
inants of widely consumed food types in France, and are 
also present in shellfish and water samples collected from 
French coastal and estuarine areas (Hervio-Heath et  al. 
2002).
Page 6 of 9Deshayes et al. SpringerPlus  (2015) 4:575 
So there is a need to increase the capacity to ensure prompt 
diagnosis and public health notification and investigation for 
effective patient management and infection control. Physi-
cians in temperate countries should be aware of these infec-
tions, to ensure they request the detection of Vibrio in faeces 
in cases of gastroenteritis after seafood consumption, and to 
ensure they warn individuals, particularly those presenting 
with predisposing conditions for bacteraemia (liver disease, 
alcoholism, diabetes, neoplasia) on the risk of ingesting raw 
or undercooked seafood or bathing in potentially infected 
waters during warm summers. All cases must be reported 
and confirmed by the National Reference Centre.
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